Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide
Owkin builds best-in-class predictive biomedical AI models and robust data sets
The programme will be implemented across 13 states and benefit 256 min
Jardiance is the first SGLT2-inhibitor therapy to prove reduction in risk of cardiovascular death in people with type-II diabetes and established cardiovascular disease
.jpg)
Molbio Diagnostics has been the pioneer in providing access to molecular testing through its Truenat Real Time PCR platform. Sriram Natarajan, Director & CEO, of the company shares his experiences on the journey so far in an interview with Thomas C Thottathil
Five potential first-in-class assets aimed at delivering significant long-term growth. Over 14 clinical development programs underway across portfolio and 11 new studies to start in 2022 across early- and late-stage pipeline
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
Subscribe To Our Newsletter & Stay Updated
